Patient Perspectives on Decentralized Clinical Trials

This white paper by Medidata’s Patient Insights team and Canary Advisors discusses patient perspectives on decentralized clinical trials (DCTs), which enable patients to complete study activities remotely. The paper outlines benefits such as geographical accessibility and addressing barriers to participation, as well as challenges such as the need for user-friendly technology and clear messaging. 

The industry should simplify and standardize messaging to make DCT methodology available and understandable to the general public. DCTs have potential to improve the clinical trial experience for everyone involved.